Pathogenic mechanisms in Fabry disease. [PDF]
Front Med (Lausanne)Wang S, Sun C.
europepmc +1 more source
Evaluating the relationship between antidrug antibodies and efficacy and safety outcomes in patients with Fabry disease receiving enzyme replacement therapy: a systematic literature review. [PDF]
Orphanet J Rare DisAguiar P, Bernat JA, Hughes D.
europepmc +1 more source
Automatic Coregistration of High-Resolution MALDI-MSI and Raman Imaging Applied to Cardiac Tissue of Fabry Disease Mouse Models. [PDF]
Anal ChemDierks J +7 more
europepmc +1 more source
Modeling Fabry nephropathy: insights from experimental systems towards precision nephrology. [PDF]
Dis Model MechElsaid H +4 more
europepmc +1 more source
Synthesis and In Vivo Immunological Evaluation of Novel Saponin-Antigen Conjugates Incorporating Tumor-Associated Carbohydrate and Peptide Epitopes. [PDF]
ChemistryFuentes R +3 more
europepmc +1 more source
The quiet reservoir: Understanding Shiga toxin Escherichia coli O157:H7 colonization in cattle. [PDF]
PLoS PathogFeldmann KP, Myer PR.
europepmc +1 more source
Impaired motor unit profile in Fabry disease: A quantitative electrophysiological study. [PDF]
Clin Neurophysiol PractGunduz A +4 more
europepmc +1 more source
Solid-Phase Glycolipid Synthesis Expedites Liposome Functionalization. [PDF]
J Am Chem SocSigler M +5 more
europepmc +1 more source
From diagnosis to disease-specific treatment: first experience with enzyme replacement therapy for Fabry disease in North Macedonia-a case series. [PDF]
Front Med (Lausanne)Karanfilovski V +6 more
europepmc +1 more source
Clinical outcomes of agalsidase Beta (fabrazyme) in Chinese fabry disease patients with proteinuria: a case series. [PDF]
Front PediatrHe Z, Wu Y, Yang H, Li Y, Xu L.
europepmc +1 more source